Press Release argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc. 3 hours ago
Press Release argenx announces Extraordinary General Meeting of Shareholders on September 17, 2026 Aug 3
Press Release argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline Jul 26
Press Release argenx Reports Half Year 2026 Financial Results and Provides Second Quarter Business Update Jul 22